Global Hyperphosphatemia Drugs Market to Grow 12.5% to 2015 Says New Report

The report ‘Global Hyperphosphatemia Drugs Market 2011-2015’ states that the Hyperphosphatemia drugs market will grow 12.5% to 2015. One of the major factors driving this market growth is the increasing prevalence of chronic kidney disease. The Hyperphosphatemia drugs market has also been witnessing the trend of an growing number of strategic alliances among vendors. However, side effects caused by the hyperphosphatemia drugs could pose a challenge to the growth of this market.

The report covers theAmericas, and the EMEA andAPACregions; it also covers the Global Hyperphosphatemia Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market including: Fresenius Medical Care AG & Co. KGaA, Shire plc, and SanofiS.A.

View the Report: ‘Global Hyperphosphatemia Drugs Market 2011-2015’

press@reportbuyer.com

44 (0) 20 7060 7474

Reportbuyer.com is the online store for global business information. The website now lists more than 200,000 company overviews, market research reports, industry studies and business books from over 300 specialist publishers. Thousands of professionals from across the world make ReportBuyer.com their first choice in their search for quality business insight.

Tags: